These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20451750)

  • 1. Re: Burke et al.: systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction (Urology 2010;75: 1015-1022).
    Mamoulakis C; de la Rosette JJ; Ubbink DT
    Urology; 2010 May; 75(5):1235-6; author reply 1236-7. PubMed ID: 20451750
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.
    Ahyai SA; Gilling P; Kaplan SA; Kuntz RM; Madersbacher S; Montorsi F; Speakman MJ; Stief CG
    Eur Urol; 2010 Sep; 58(3):384-97. PubMed ID: 20825758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KTP/LBO laser vaporization of the prostate.
    Wosnitzer MS; Rutman MP
    Urol Clin North Am; 2009 Nov; 36(4):471-83, vi. PubMed ID: 19942046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
    Yu B; Wang Z
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transurethral needle ablation of the prostate.
    Tubaro A; De Nunzio C; Miano R
    Curr Opin Urol; 2007 Jan; 17(1):7-11. PubMed ID: 17143104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimally invasive treatment of benign prostatic hyperplasia].
    Nørby B
    Ugeskr Laeger; 2004 Feb; 166(8):688-90. PubMed ID: 15042812
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on minimally invasive therapies for benign prostatic hyperplasia.
    Turini GA; Pareek G
    Med Health R I; 2009 Oct; 92(10):336-8. PubMed ID: 19911713
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroresection and open surgery.
    Thiel DD; Petrou SP
    Urol Clin North Am; 2009 Nov; 36(4):461-70, vi. PubMed ID: 19942045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental treatments for benign prostatic obstruction.
    Seki N; Naito S
    Curr Opin Urol; 2007 Jan; 17(1):17-21. PubMed ID: 17143106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Rubiao et al.: A randomized trial of transvesical prostatectomy versus transurethral resection of the prostate for prostate greater than 80 mL (Urology 2010;76;958-961).
    Shenoy SP; Marla PK; Adappa KK
    Urology; 2011 Mar; 77(3):764; author reply 764-5. PubMed ID: 21377023
    [No Abstract]   [Full Text] [Related]  

  • 15. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications.
    Larson BT; Bostwick DG; Corica AG; Larson TR
    J Urol; 2003 Jul; 170(1):12-9. PubMed ID: 12796636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of benign prostatic hyperplasia: current evidence.
    Baazeem A; Elhilali MM
    Nat Clin Pract Urol; 2008 Oct; 5(10):540-9. PubMed ID: 18836463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome.
    Furuya R; Masumori N; Furuya S; Oda T; Takahashi S; Takeuchi M
    Urology; 2007 Nov; 70(5):922-6. PubMed ID: 18068448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Chen et al.: Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-w high-intensity laser (Urology 2010;75:658-663).
    Shenoy SP; Marla PK; Tantry TP
    Urology; 2011 Mar; 77(3):765-6. PubMed ID: 21377024
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostatic stents for the treatment of benign prostatic hyperplasia.
    Vanderbrink BA; Rastinehad AR; Badlani GH
    Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.